Todisco, E., Papayannidis, C., Fracchiolla, N., Cerchione, C., Marconi, G., Petracci, E., et al. (2021). OUTCOMES OF RELAPSED OR REFRACTORY AND NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT AND VENETOCLAX. THE ITALIAN REAL-LIFE EXPERIENCE BEFORE PUBLIC HEALTH REIMBURSEMENT (AVALON STUDY). Intervento presentato a: 48th congress of italian society of hematology, Milano, Italia.

OUTCOMES OF RELAPSED OR REFRACTORY AND NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT AND VENETOCLAX. THE ITALIAN REAL-LIFE EXPERIENCE BEFORE PUBLIC HEALTH REIMBURSEMENT (AVALON STUDY)

Cairoli, R
Membro del Collaboration Group
;
2021

paper
Hematology
English
48th congress of italian society of hematology
2021
2021
106
10 S3
15
16
C014
none
Todisco, E., Papayannidis, C., Fracchiolla, N., Cerchione, C., Marconi, G., Petracci, E., et al. (2021). OUTCOMES OF RELAPSED OR REFRACTORY AND NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT AND VENETOCLAX. THE ITALIAN REAL-LIFE EXPERIENCE BEFORE PUBLIC HEALTH REIMBURSEMENT (AVALON STUDY). Intervento presentato a: 48th congress of italian society of hematology, Milano, Italia.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/409339
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact